| 000 | 01917 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517123601.0 | ||
| 264 | 0 | _c20170926 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1471-2407 | ||
| 024 | 7 |
_a10.1186/s12885-016-2868-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGandhi, Mihir | |
| 245 | 0 | 0 |
_aSingle administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): study protocol for a phase iii randomized controlled trial. _h[electronic resource] |
| 260 |
_bBMC cancer _c11 2016 |
||
| 300 |
_a856 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBrachytherapy _xmethods |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xpathology |
| 650 | 0 | 4 | _aClinical Protocols |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Neoplasms _xpathology |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPhenylurea Compounds _xtherapeutic use |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aResearch Design |
| 650 | 0 | 4 | _aSorafenib |
| 700 | 1 | _aChoo, Su Pin | |
| 700 | 1 | _aThng, Choon Hua | |
| 700 | 1 | _aTan, Say Beng | |
| 700 | 1 | _aLow, Albert Su Chong | |
| 700 | 1 | _aCheow, Peng Chung | |
| 700 | 1 | _aGoh, Anthony Soon Whatt | |
| 700 | 1 | _aTay, Kiang Hiong | |
| 700 | 1 | _aLo, Richard Hoau Gong | |
| 700 | 1 | _aGoh, Brian Kim Poh | |
| 700 | 1 | _aWong, Jen San | |
| 700 | 1 | _aNg, David Chee Eng | |
| 700 | 1 | _aSoo, Khee Chee | |
| 700 | 1 | _aLiew, Wei Ming | |
| 700 | 1 | _aChow, Pierce K H | |
| 773 | 0 |
_tBMC cancer _gvol. 16 _gno. 1 _gp. 856 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12885-016-2868-y _zAvailable from publisher's website |
| 999 |
_c26583861 _d26583861 |
||